UiPath shares have had a tough start to the year, but the company has a big potential opportunity ahead.
It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption ...
Martin Oswald, Head of Operational Transformation at Travelodge, explains how a deliberate, colleague-first approach to ...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. UiPath’s blended fair value estimate has been trimmed from US$16.19 to US$15.93, a ...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. UiPath (NYSE:PATH) has launched agentic AI automation tools tailored for healthcare ...
UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...
Weeping Peninsula (South Limgrave) - Dungeons, Points of Interest, and Secrets East Liurnia - Dungeons, Points of Interest, and Secrets North Liurnia - Dungeons, Points of Interest, and Secrets West ...
UiPath (PATH) is scheduled to report Q1 earnings on May 28, 2026. Analysts estimate EPS of $0.16 and quarterly revenue of $464.83M. In the most recent quarter (Q4), UiPath reported EPS of $0.30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results